Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for SKVI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 0.00%
March 31, 2026 0.00%
December 31, 2025 -2.00%
September 30, 2025 -2.00%
June 30, 2025 -2.00%
March 31, 2025 2.00%
December 31, 2024 0.00%
September 30, 2024 -18.00%
June 30, 2024 4.00%
March 31, 2024 6.00%
December 31, 2023 6.00%
September 30, 2023 10.00%
June 30, 2023 4.00%
March 31, 2023 8.00%
December 31, 2022 6.00%
September 30, 2022 13.98%
June 30, 2022 97.71%
March 31, 2022 89.83%
December 31, 2021 98.14%
September 30, 2021 0.00%
June 30, 2021 0.00%
March 31, 2021 37.19%
December 31, 2020 0.00%
September 30, 2020 0.00%
June 30, 2020 0.00%
Date Value
March 31, 2020 0.00%
December 31, 2019 -87.04%
September 30, 2019 7.96%
June 30, 2019 -29.92%
March 31, 2019 -20.24%
December 31, 2018 21.09%
September 30, 2018 27.27%
June 30, 2018 16.59%
March 31, 2018 -12.18%
December 31, 2017 0.00%
September 30, 2017 68.24%
June 30, 2017 -34.53%
March 31, 2017 -24.80%
December 31, 2016 0.00%
September 30, 2016 -179.8%
June 30, 2016 37.53%
March 31, 2016 32.51%
December 31, 2015 4.32%
September 30, 2015 19.41%
June 30, 2015 -1.83%
March 31, 2015 73.84%
December 31, 2014 -156.6%
September 30, 2014 53.36%
June 30, 2014 -16.85%
March 31, 2014 -11.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 69.90%
Integrated BioPharma, Inc. -2.73%
BioForce Nanosciences Holdings, Inc. --
Nevis Brands, Inc. -20.14%
Skinhealth Systems, Inc. 68.42%

Gross Profit Margin (Quarterly) Related Metrics